postoperative analgesia
Conditions
Interventions
Ropivacaine group:quadratus lumborum block with 0.2% ropivacaine
Low dose dexmedetomidine group:quadratus lumborum block with 0.2% ropivacaine combined with 0.25 ug/kg dexmedetomidine
Middle dose dexmedetomidine group:quadratus lumborum block with 0.2% ropivacaine combined with 0.5 ug/kg dexmedetomidine
High dose dexmedetomidine group:quadratus lumborum block with 0.2% ropivacaine combined with 0.75 ug/kg dexmedetomidine
Sponsors
Jieyang People's Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as "uterine fibroids", undergoing laparoscopic hysterectomy 2. Aged 18 to 65 years 3. Body mass index was 18 to 25 kg/m2 4. The American Society of Anesthesiologists (ASA) classification (anesthesia risk assessment) is I or ? level 5. Patients who voluntary participation in clinical trials and signed the informed consent form
Exclusion criteria
Exclusion criteria: Combined with malignant tumor,hypertension, diabetes,heart disease, adrenal gland diseases and severe hepatic and renal dysfunction; combined with chronic pain and bradycardia; long-term use of corticosteroids, analgesics, adrenergic agonists and antagonists; alcohol, nicotine and opioid dependence; local anesthetics allergy; turn to laparotomy; fail to quadratus lumborum block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores in rest;VAS scores during coughing;sedation scores;plasma cortisol;blood glucose;BCS Comfort rating;Quality of recovery;QoR -15 scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative analgesia satisfaction; | — |
Countries
China
Contacts
Public ContactLongsheng Zhang
Jieyang People's Hospital
Outcome results
None listed